Skip to content

Clinical trials

Completed Phase 3 Liver Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 3 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20021
20053
20063
20073
20084
20094
20102
20111
20123
20132
20142
20152
20161
20171
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University5
Bayer4
Bracco Diagnostics, Inc2
Bristol-Myers Squibb2
Imunon2
Light Sciences Oncology2
Memorial Sloan Kettering Cancer Center2
National Medical Research Council (NMRC), Singapore2
Alliance for Clinical Trials in Oncology1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms40
Carcinoma, Hepatocellular21
Neoplasms4
Bile Duct Neoplasms3
Colorectal Neoplasms3
Hepatoblastoma3
Neoplasm Metastasis3
Agnosia2
Gallbladder Neoplasms2
Ototoxicity2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.